China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical evaluation and strategy optimization of antiviral therapy for pregnant women with high HBV viral load in Ningxia: a multicenter real-world cohort study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133361

Registration Time: 2026/09/24

Type: Observational study

Primary Sponsor: Peking University First Hospital Ningxia Women and Children's Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344842

Published by HT Digital Content Services with permission from Health Daily...